RGS RGS Healthcare Solutions

Tender glossary

Marketing authorisation holder (MAH)

Also known as: MAH, licence holder

Definition

The company named on a medicine's marketing authorisation and legally responsible for it in a given market; it is not necessarily the company that manufactures the product.

In practice

Generics are often made by one company and sold under another's authorisation, and the same molecule can have dozens of holders across Europe. Tracking holders over time shows new entrants, withdrawals and transfers between companies.

Example

A generic is sold in Germany under one company's authorisation, in France under another's, and made by a third company for both. The holder in each country is who you meet in tenders; the manufacturer is who determines supply.

Where it matters most

Back to the glossary

See how this plays out in your own tenders

RGS tracks tenders and awards across Europe and applies these rules automatically.